Kymera Therapeutics Inc.
EPS
| Fiscal Year | EPS | Cyclically Adjusted EPS |
|---|---|---|
| FY2019 | $-8.09 | $-9.93 |
| FY2020 | $-1.05 | $-5.60 |
| FY2021 | $-2.09 | $-4.54 |
| FY2022 | $-2.87 | $-4.17 |
| FY2023 | $-2.52 | $-3.86 |
| FY2024 | $-2.98 | $-3.71 |
| FY2025 | $-3.69 | $-3.71 |
EPS
| Fiscal Year | EPS | Cyclically Adjusted EPS |
|---|---|---|
| FY2019 | $-8.09 | $-9.93 |
| FY2020 | $-1.05 | $-5.60 |
| FY2021 | $-2.09 | $-4.54 |
| FY2022 | $-2.87 | $-4.17 |
| FY2023 | $-2.52 | $-3.86 |
| FY2024 | $-2.98 | $-3.71 |
| FY2025 | $-3.69 | $-3.71 |